We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
5 Reasons to Add Cabot (CBT) Stock to Your Portfolio Now
Read MoreHide Full Article
Cabot Corporation’s (CBT - Free Report) stock looks promising at the moment. We are positive on the company’s prospects and believe that the time is right for you to add the stock to portfolio as it looks promising and is poised to carry the momentum ahead.
Let’s delve deeper into the factors that make this chemical company an attractive investment option.
What’s Working in Favor of CBT?
Solid Rank & VGM Score: Cabot currently sports a Zacks Rank #2 (Buy) and a VGM Score of A. Our research shows that stocks with a VGM Score of A or B, combined with a Zacks Rank #1 (Strong Buy) or #2, offer the best investment opportunities for investors. Thus, the company appears to be a compelling investment proposition at the moment.
An Outperformer: Cabot has outperformed the industry over the past six months. The company’s shares have gained around 15.6% over this period, compared with roughly 3% growth recorded by the industry.
Healthy Growth Prospects: The Zacks Consensus Estimate for earnings for fiscal 2018 for Cabot is currently pegged at $4.12, reflecting an expected year-over-year growth of 20.1%. Moreover, earnings are expected to register a 14.7% growth in fiscal 2019. The company also has an expected long-term earnings per share growth rate of 11%.
Superior Return on Equity (ROE): Cabot’s ROE of 17.4%, as compared with the industry average of 9.6%, manifests the company’s efficiency in utilizing shareholder’s funds.
Upbeat Prospects: Cabot, during its fiscal third quarter call, said that it expects its Reinforcement Materials segment to continue performing strongly in the fiscal fourth quarter on the back of solid operational and commercial execution. For the Performance Chemicals segment, the company expects to maintain margins while driving volume growth in specialty Carbons and Formulations.
The Reinforcement Materials segment is benefiting from strong commercial execution that is driving volumes and margin growth. The Performance Chemicals unit is also gaining from favorable impact from price increase actions. Cabot is taking appropriate pricing actions to offset feedstock cost inflation. The company also remains committed to drive product mix in Performance Chemicals through new product launches and applications.
Moreover, Cabot is expanding its specialty compounds business globally. The acquisition of Tech Blend and commissioning of a new production line at its manufacturing facility in Belgium will help the company expand its global footprint in black masterbatch and compounds. It will also help boost manufacturing capacity to better serve customers globally and grow in advanced polymeric materials.
Cabot, in May, also declared significant expansion of capacity of its global network of carbon black plants. It is expanding its global capacity by more than 300,000 metric tons through a combination of operational improvements, plant expansion and debottlenecking projects.
ArcelorMittal has an expected long-term earnings growth rate of 4.8%. The company’s shares are up roughly 17% in a year.
Nucor has an expected long-term earnings growth rate of 12%. The company’s shares have gained around 16% in a year.
Quaker Chemical has an expected long-term earnings growth rate of 11%. The company’s shares have rallied around 35% in a year.
Best Electric Car Stock? You'll Never Guess It.
Zacks Research has released a report that may shock many investors. One stock stands out as the best way to invest in the surge to electric cars. And it's not the one you may think!
Much like petroleum 150 years ago, lithium battery power is set to shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge. With battery prices plummeting and charging stations set to multiply, revenues that were already at $31 billion in 2016 are expected to blast to over $67 billion by the end of 2022.
Image: Bigstock
5 Reasons to Add Cabot (CBT) Stock to Your Portfolio Now
Cabot Corporation’s (CBT - Free Report) stock looks promising at the moment. We are positive on the company’s prospects and believe that the time is right for you to add the stock to portfolio as it looks promising and is poised to carry the momentum ahead.
Let’s delve deeper into the factors that make this chemical company an attractive investment option.
What’s Working in Favor of CBT?
Solid Rank & VGM Score: Cabot currently sports a Zacks Rank #2 (Buy) and a VGM Score of A. Our research shows that stocks with a VGM Score of A or B, combined with a Zacks Rank #1 (Strong Buy) or #2, offer the best investment opportunities for investors. Thus, the company appears to be a compelling investment proposition at the moment.
An Outperformer: Cabot has outperformed the industry over the past six months. The company’s shares have gained around 15.6% over this period, compared with roughly 3% growth recorded by the industry.
Healthy Growth Prospects: The Zacks Consensus Estimate for earnings for fiscal 2018 for Cabot is currently pegged at $4.12, reflecting an expected year-over-year growth of 20.1%. Moreover, earnings are expected to register a 14.7% growth in fiscal 2019. The company also has an expected long-term earnings per share growth rate of 11%.
Superior Return on Equity (ROE): Cabot’s ROE of 17.4%, as compared with the industry average of 9.6%, manifests the company’s efficiency in utilizing shareholder’s funds.
Upbeat Prospects: Cabot, during its fiscal third quarter call, said that it expects its Reinforcement Materials segment to continue performing strongly in the fiscal fourth quarter on the back of solid operational and commercial execution. For the Performance Chemicals segment, the company expects to maintain margins while driving volume growth in specialty Carbons and Formulations.
The Reinforcement Materials segment is benefiting from strong commercial execution that is driving volumes and margin growth. The Performance Chemicals unit is also gaining from favorable impact from price increase actions. Cabot is taking appropriate pricing actions to offset feedstock cost inflation. The company also remains committed to drive product mix in Performance Chemicals through new product launches and applications.
Moreover, Cabot is expanding its specialty compounds business globally. The acquisition of Tech Blend and commissioning of a new production line at its manufacturing facility in Belgium will help the company expand its global footprint in black masterbatch and compounds. It will also help boost manufacturing capacity to better serve customers globally and grow in advanced polymeric materials.
Cabot, in May, also declared significant expansion of capacity of its global network of carbon black plants. It is expanding its global capacity by more than 300,000 metric tons through a combination of operational improvements, plant expansion and debottlenecking projects.
Cabot Corporation Price and Consensus
Cabot Corporation Price and Consensus | Cabot Corporation Quote
Other Stocks to Consider
Other top-ranked stocks worth considering in the basic materials space include ArcelorMittal (MT - Free Report) , Nucor Corporation (NUE - Free Report) and Quaker Chemical Corporation (KWR - Free Report) , each carrying a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.
ArcelorMittal has an expected long-term earnings growth rate of 4.8%. The company’s shares are up roughly 17% in a year.
Nucor has an expected long-term earnings growth rate of 12%. The company’s shares have gained around 16% in a year.
Quaker Chemical has an expected long-term earnings growth rate of 11%. The company’s shares have rallied around 35% in a year.
Best Electric Car Stock? You'll Never Guess It.
Zacks Research has released a report that may shock many investors. One stock stands out as the best way to invest in the surge to electric cars. And it's not the one you may think!
Much like petroleum 150 years ago, lithium battery power is set to shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge. With battery prices plummeting and charging stations set to multiply, revenues that were already at $31 billion in 2016 are expected to blast to over $67 billion by the end of 2022.
See Zacks Best EV Stock Free >>